Evaluating New Radiation Techniques for Cardiovascular Imaging
Study Details
Study Description
Brief Summary
Title: Evaluating New Radiation Techniques for Cardiovascular Imaging
Background:
- Imaging studies such as computed tomography (CT) scans involve the use of radiation to create the pictures. Heart and blood vessel CT scans can cause high radiation exposure. Different methods of creating CT pictures have been developed to reduce the radiation dose. Researchers want to see how effective these new methods are in producing accurate CT scans.
Objectives:
- To study new ways of taking pictures of the heart or blood vessels using computed tomography.
Eligibility:
- Adults at least 18 years of age who will be having imaging studies to help detect heart or blood vessel problems.
Design:
-
Participants will be screened with a physical exam and medical history. Blood samples will be taken to check kidney function.
-
Participants will have a CT scan of the heart and blood vessels. A contrast agent may be used to improve the quality of the images. The scanning session may last up to 2 hours.
-
Participants will have follow-up contact 90 days after the scan, and then yearly contact for the next 5 years.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Cardiac CT angiography is associated with radiation exposure. Different methods of creating CT pictures have been developed to reduce the radiation dose to the subject. The purpose of this research study is to learn whether these new imaging methods are accurate or predict subject outcomes.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: 1 Subjects with Clinical indication for a coronary CT angiography exam |
Device: The Toshiba Aquilion ONE CT system
To test the diagnostic accuracy of low-radiation dose CT coronary angiography for detecting significant coronary artery stenosis and to determine the prognostic value of low-radiation dose CT coronary angiography for discriminating patient risk of death or major adverse cardiac events.
|
Outcome Measures
Primary Outcome Measures
- new imaging methods are accurate or predict subject outcomes. [ongoing]
Compare time-to-first cardiovascular events (death, revascularization more than 90 days after CTA, hospitalization, non-fatal myocardial infarction, stroke) in subjects with >=50% coronary stenosis vs. <50% stenosis.
Secondary Outcome Measures
- Estimate radiation dose from clinically performed cardiovascular CT. [ongoing]
The purpose of this research study is to learn whether these new imaging methods are accurate or predict subject outcomes.
- Survival analysis of subjects identified by CT with significant coronary artery disease (=50% stenosis) vs. subjects without significant coronary artery disease (<50% stenosis). [ongoing]
The purpose of this research study is to learn whether these new imaging methods are accurate or predict subject outcomes.
- Evaluate image quality from new CT technology. [ongoing]
The purpose of this research study is to learn whether these new imaging methods are accurate or predict subject outcomes.
- Estimate diagnostic accuracy of cardiovascular evaluations using new CT technology vs. invasive angiography and versus stress perfusion MRI. [ongoing]
The purpose of this research study is to learn whether these new imaging methods are accurate or predict subject outcomes.
Eligibility Criteria
Criteria
- INCLUSION CRITERIA:
-
Clinical indication for a coronary CT angiography exam
-
Age equal to or greater than 18 years
-
Able to understand and willing to sign the Informed Consent Form
-
Able and willing to provide follow-up information
EXCLUSION CRITERIA:
-
Pregnancy
-
If receiving intravenous contrast, severe renal excretory dysfunction, estimated glomerular filtration rate < 30 mL/min/1.73m2 body surface area according to the Modification of Diet in Renal Disease criteria or as reported by the clinical lab. Glomerular filtration rate will be estimated using the MDRD 2005 revised study formula: eGFR (mL/min/1.73m2) = 175 x (standardized serum creatinine)-1.154 x (age)-0.203 x 0.742 (if the subject is female) or x 1.212 (if the subject is black)
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | National Institutes of Health Clinical Center | Bethesda | Maryland | United States | 20892 |
Sponsors and Collaborators
- National Heart, Lung, and Blood Institute (NHLBI)
Investigators
- Principal Investigator: Marcus Y Chen, M.D., National Heart, Lung, and Blood Institute (NHLBI)
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
- 120141
- 12-H-0141